The price sits 98.4% of the way up its 52-week range, close to its 52-week high.

Price is the close for 3 Sep 2026, sourced from Yahoo Finance and checked against the 52-week range before publishing. Delayed and for research only — not investment advice.

Price chart

Earnings per share

Diluted EPS taken directly from Amgen's filings with the US Securities and Exchange Commission, for the quarter ended 30 Jun 2026. View the filings on EDGAR. Trailing figures sum the last four reported quarters.

Which ETFs hold AMGN?

Amgen appears in 2 of the funds we track, with its heaviest allocation at 3.50% in SCHD.

What this means for your portfolio

If you hold more than one of the funds listed above, your exposure to Amgen is the sum of its weight in each — not the weight shown on any single fund page. This is how investors end up far more concentrated in a handful of companies than they intended, particularly when a broad market fund and a sector or thematic fund are held side by side.

Across the 2 funds holding it, the average published weight is 3.35%.

Other healthcare holdings

Community

AMGN discussion

Questions on fair value, cost, dividends and risk — answered with the fund data on this page.

How should you assess the fair value of AMGN (Amgen Inc.)?

Fair value 2 answers ETFWinner Research

Which ETFs hold AMGN, and how much exposure do you already have?

Holdings 2 answers ETFWinner Research

AMGN stock forecast 2026: what the data does and does not tell you

Price outlook 2 answers ETFWinner Research

Ask a question about AMGN

Questions are reviewed before publishing. Please do not ask for personal investment advice — we cannot provide it.

Website

Your question More detail (optional) Your name Post question